FDA Restricts Usage Of Sanofi-Aventis (France)'s Ketek

February 13, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON, February 13 (newratings.com) – Sanofi-Aventis SA’s (SNW.ETR) antibiotic Ketek should not be used for the treatment of sinusitis and bronchitis, US officials warned on Monday.

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

Europe

Food and Drug Administration (FDA) Sanofi (France)